JPM25: BMS, Pfizer and Merck CEOs address key patent cliffs and plans to replace sales
Each year at the J.P. Morgan Healthcare Conference, pharma CEOs are tasked with assuring and convincing investors that they’ve positioned their companies to overcome expected challenges. Monday, three Big Pharma leaders took center stage and addressed …